default author photo

Ricky Rui-Qi Zhang

The University of Hong Kong - Li Ka Shing Faculty of Medicine

SCHOLARLY PAPERS

2

DOWNLOADS

496

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Boosting of Serum Neutralizing Activity Against the Omicron Variant Among Recovered COVID-19 Patients by BNT162b2 and Coronavac Vaccines

Number of pages: 36 Posted: 08 Feb 2022
Lu Lu, Lin-Lei Chen, Ricky Rui-Qi Zhang, Owen Tak-Yin Tsang, Jacky Man-Chun Chan, Anthony Raymond Tam, Wai-Shing Leung, Thomas Shiu-Hong Chik, Daphne Pui-Ling Lau, Chris Yau-Chung Choi, Carol Ho-Yan Fong, Jian-Piao Cai, Hoi-Wah Tsoi, Charlotte Yee-Ki Choi, Xiaojuan Zhang, Syed Muhammad Umer Abdullah, Brian Pui-Chun Chan, Kwok-Hung Chan, Kwok-Yung Yuen, Ivan Fan Ngai Hung and Kelvin Kai-Wang To
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Li Ka Shing Faculty of Medicine, Princess Margaret Hospital - Department of Medicine, The University of Hong Kong, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, Southern Medical University - Division of Laboratory Medicine, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - School of Clinical Medicine and The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Downloads 421 (172,704)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Omicron variant, Neutralizing antibody, Surrogate neutralizing antibody test, spike protein receptor binding domain, Variants of Concern

2.

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal Delns1-nCoV-RBD LAIV for COVID-19 in Healthy Adults

Number of pages: 32 Posted: 20 Jun 2022
Ricky Rui-Qi Zhang, Kwok-Hung Chan, Pui Wang, Runhong Zhou, Henry Kwong-Chi Yau, Creany Ka-Wai Wong, Meena Wai-Lam Au, Anthony Raymond Tam, Chi-Tao Ng, Matthew Kwok-Chung Lou, Na Liu, Haode Huang, Shaofeng Deng, Chun-Yee Tam, Ying Liu, Teng Long, Hoi-Wah Tsoi, Miko KW Ng, Jian-Piao Cai, Kelvin Kai-Wang To, Man-Fung Yuen, Zhiwei Chen, Honglin Chen, Kwok-Yung Yuen and Ivan Fan Ngai Hung
The University of Hong Kong - Li Ka Shing Faculty of Medicine, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - AIDS Institute, The University of Hong Kong - AIDS Institute, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Queen Mary Hospital, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases and The University of Hong Kong - School of Clinical Medicine
Downloads 75 (837,727)

Abstract:

Loading...

Phase-1, intranasal, DelNS1-nCoV-RBD LAIV, COVID-19